Delivering Hope

Partnership objectives

  1. Increase awareness of hepatitis B and C and reduce stigma associated with the diseases.
  2. Promote hepatitis prevention, especially among groups most at risk.
  3. Support hepatitis education and disease management training for healthcare workers
  4. Fund operational research to develop data and demonstration projects that generate best practices to be shared, adapted and applied in the future.

Delivering Hope™ is a comprehensive effort to fight hepatitis B and hepatitis C in Asia. Delivering Hope™ is a comprehensive effort to fight hepatitis B and hepatitis C in Asia. Copyright BMS

What are the health needs and challenges?

Lack of awareness about hepatitis hinders disease prevention and management in developing countries in Asia, particularly China and India. China and India together have an estimated 123 million people chronically infected with hepatitis B (HBV) and 60 million people chronically infected with hepatitis C (HCV), accounting for almost 50% of all HBV and HCV infections worldwide.

In China, about 40 million people are infected with HCV. Surging HCV incidence rates led the Chinese government to declare HCV an urgent public health issue. Prevalence of HCV is estimated to continue to grow, and associated co-morbidities such as liver disease, cirrhosis and cancer are a growing health concern.

Chronic hepatitis, when left untreated, can lead to cirrhosis of the liver and liver cancer.

Description of partnership activities and how they address needs and challenges

Delivering Hope™: Awareness, Prevention and Care is a comprehensive effort to fight HBV and HCV in Asia, sponsored by the Bristol-Myers Squibb Foundation. Delivering Hope draws upon the proven models created by the Foundation's work on HIV/AIDS in Africa to address a major health care challenge in resource-constrained settings.

The Foundation and its partners in China and India are working to increase hepatitis awareness among the general population and lay health care workers, especially in remote, rural areas. Efforts include disease education, vaccination and programs to help prevent mother-to-child transmissions, which are the most common means of transmission of hepatitis. Delivering Hope focuses on children as a way of building family and community awareness. In addition, in 2014 Delivering Hope established three Centers of Excellence, one in China and two in India, which focus on awareness, prevention and treatment of hepatitis. 

Delivering Hope™ has four objectives: (1) increasing public awareness of hepatitis and reducing the stigma associated with the disease; (2) promoting disease prevention, especially among groups most at risk; (3) supporting disease education and disease management training for health care workers; and (4) funding operational research to develop data and demonstration projects that generate best practices to be shared, adapted and applied in the future.

These efforts are helping to develop a portfolio of projects that aims to raise the profile of the disease in Asia, inform health policy and national programs, build institutional and community capacity, and target prevention in the hardest-hit populations including children, blood donors and health care professionals.

Summary of impact and forward looking information

Since 2002, the Foundation has awarded grants to 19 organizations totalling USD 14 million to organizations working to reduce hepatitis-related health disparities in Asia. To date, Delivering Hope has supported 50 program grants across Asia, specifically 20 grants in mainland China, three in Taiwan, 22 in India and five in Japan, benefiting over 700,00 people directly.

More than 26 million individuals living in areas disproportionately impacted by hepatitis across Asia have benefitted from the BMSF’s Delivering Hope-related education and awareness programmes, including:

  • Training of more than 163,000 health workers
  • Nearly 600,000 people vaccinated

Partnership information

Company(ies) Bristol-Myers Squibb

Partner(s) AmeriCares India, Asia Pacific Alliance against AIDS, Tuberculosis and Malaria, Baptist Christian Hospital, Chang Memorial Hospital, China Foundation for Hepatitis Prevention and Control, Christian Medical College of Vellore, Hepatitis B Foundation, Hepatitis Foundation of Tripura, Hope Initiative – B-Rodh, Kaohsiung Medical University Hospital, Liver Disease Prevention and Treatment Research Foundation, Liver Foundation West Bengal, National Liver Foundation, Federation of Bombay Blood Banks, Shanghai Charity Foundation, United Way of Mumbai, Wu Jipieng Medical Foundation

Type of Partner(s) Academia / Hospitals, NGOs

Therapeutic Focus Vaccine-Preventable Diseases

Disease(s) Hepatitis

Program Type(s) Health System Infrastructure - Development of Physical Infrastructure, Health System Infrastructure - Training, Prevention Programs - Awareness & Outreach

Targeted Population(s) Patients in needs of treatment, People with low income

Region(s) East Asia & Pacific, South Asia

Number of Countries 3

Country(ies) China, India, Japan

Start Date 2002

More information Delivering Hope

Anticipated completion date Ongoing

« The help extended…is invaluable. It has allowed us to look into the lives of many and reassure them regarding their future. It has replaced despair and doubt with hope and reassurance. »

Dr. Piyush Sharma of India’s National Liver Foundation